The Avian Influenza Wildfire: How H5N1 Is Rewriting the Global Food System's Risk Calculus
The current outbreak of highly pathogenic avian influenza H5N1 is unlike any that preceded it in scale, geographic reach, and the breadth of species affected. Previous HPAI outbreaks were serious, cyclical disruptions to the poultry industry — economically costly and operationally difficult, but ultimately contained within a predictable epidemiological pattern. This one is different. Since 2021, H5N1 has spread to every continent except Australia, has caused mass mortality events in wild bird populations across Europe, the Americas, and Africa, and has crossed into mammalian species — including dairy cattle in the United States — in ways that virology surveillance has not observed before at this scale. The food system implications are immediate and measurable. The public health implications are being discussed in epidemiological circles with a seriousness that is not yet reflected in mainstream commercial planning.
The commercial impact on egg and poultry markets has been severe and sustained. The United States has lost more than 100 million birds to HPAI since 2022, driving US shell egg prices to record levels and creating sustained shortages in foodservice and retail channels. Europe has experienced the largest HPAI outbreaks in its recorded history, with France in particular suffering repeated devastating losses in its duck and foie gras production sectors — losses that triggered the 2022 decision to mandate national H5 vaccination, the first such programme in the EU. The question of whether to vaccinate, and how to do it without triggering trade restriction from non-vaccinating importers, has become one of the most contested policy debates in agricultural trade, with positions that cut across the conventional free-trade versus protectionist lines.
The Vaccination Policy Divide and What It Means for Trade
The international disagreement over avian influenza vaccination is not primarily a scientific disagreement — it is a trade policy disagreement with a scientific veneer. The core issue is that traditional inactivated vaccines for HPAI are effective at preventing clinical disease and reducing mortality but do not block viral shedding and transmission completely. This creates the "DIVA problem" — differentiating infected from vaccinated animals — which matters because trade partners who do not vaccinate have historically applied import restrictions to poultry and eggs from vaccinating countries, arguing that vaccination makes it impossible to confirm freedom from infection using conventional serology.
France's decision to vaccinate despite these trade pressures was partly forced by the scale of production losses, but it also reflected a calculation that the trade consequences were manageable and that the alternative — repeated mass culling of the entire national duck population — was economically and politically unsustainable. The results of the French programme have been closely watched. Mortality in vaccinated flocks has fallen dramatically. The expected catastrophic trade consequences have not fully materialised, partly because France negotiated specific arrangements with key trading partners and partly because the scale of global H5N1 spread has made the "vaccination-free" status of non-vaccinating countries less commercially meaningful than it previously was. Italy, Germany, and the Netherlands are all moving toward vaccination, and the global policy framework is shifting from "vaccinate as last resort" toward "vaccinate as structural biosecurity tool."
Dairy Cattle Infection: The Threshold That Changes Everything
The detection of H5N1 in US dairy cattle herds beginning in early 2024 marked a qualitative shift in the outbreak's significance for food system risk assessment and for pandemic preparedness planning. Dairy cattle had not previously been considered a meaningful host for HPAI, and the finding required a rapid reassessment of both the virus's host range and the surveillance infrastructure designed to detect spillover events. The US response — voluntary testing, inconsistent state-level protocols, and significant industry resistance to mandatory surveillance — was widely criticised by epidemiologists as inadequate to the information needs of a situation where a highly pathogenic influenza virus was circulating in a species in close daily contact with large numbers of farm workers.
The dairy sector implications extend beyond immediate herd health. Milk from infected cows contains high viral loads, and while pasteurisation kills the virus, the persistence of raw milk markets and the complexity of modern dairy supply chains create exposure pathways that have not been definitively characterised. The commercial impact on US dairy exports — already under pressure from global competition — has been limited so far, but the reputational and trade restriction risk from continued spread without adequate containment is non-trivial. More significant is the human infection data: farmworkers exposed to infected dairy cattle have tested positive for H5N1 at rates that suggest the exposure frequency is higher than official case counts indicate, raising questions about the adequacy of both farm worker protection and the surveillance systems designed to detect early human spread.
Supply Chain Restructuring and the Food Industry Response
Food companies, quick-service restaurant chains, and grocery retailers that depend heavily on poultry and eggs as core commodities have been forced to operationalise risk management frameworks that most did not have in adequate form two years ago. The response has taken several forms. Diversified sourcing — both geographically and by production system — has accelerated, with buyers seeking to avoid single-country or single-region concentration that amplifies outbreak exposure. Long-term supply agreements with biosecurity premium pricing have proliferated as both buyers and sellers seek cost predictability in an environment where spot prices can move 40% in a quarter. Product reformulation to reduce egg intensity in recipes — a trend already present in response to plant-based consumer demand — has been accelerated by supply uncertainty.
The most strategically significant supply chain response is the growing interest in indoor and biosecure production systems. Conventional outdoor and free-range production systems, while preferred by consumers on welfare grounds, are fundamentally more exposed to wild bird contact and therefore to HPAI transmission. The economic case for biosecure housing — previously challenged on capital cost and animal welfare grounds — is being revised upward as the cost of repeated culling and restocking is incorporated into long-run production economics. The tension between biosecurity-driven confinement and consumer-driven welfare preferences is shaping a genuine strategic dilemma for poultry producers and their retail customers, with no resolution that satisfies all stakeholders simultaneously.
The Pandemic Preparedness Dimension: What the Food Industry Owes Public Health
Avian influenza sits at the intersection of food system risk and pandemic risk in a way that makes it uniquely difficult to manage through the siloed structures that typically govern each domain. The food industry's interest is in containing outbreaks quickly, minimising trade restrictions, and avoiding the regulatory response that would follow a large-scale human infection event. The public health system's interest is in maximising surveillance, understanding transmission dynamics, and building the vaccine and treatment stockpiles that would be needed if the virus acquired efficient human-to-human transmission capability. These interests are not always aligned, and the tension between them has been visible in the inadequacy of US farm-level surveillance and the industry resistance to mandatory reporting requirements.
The commercial food system's pandemic preparedness obligations are not yet clearly defined in regulation, but they are increasingly being raised in investor, regulatory, and public health policy discussions. A pandemic influenza event with avian origins would not only be a public health catastrophe — it would be a catastrophic commercial event for the food industry itself, with supply chain disruption, trade restriction, and demand destruction operating simultaneously at global scale. The food companies and agricultural enterprises that are building genuine surveillance and biosecurity investment into their supply chains ahead of regulatory mandate are positioning for a world where that investment becomes table stakes, not differentiator. The ones treating avian influenza as a manageable cyclical disruption rather than a structural systemic risk are, on the current evidence, misjudging the severity of the situation they are managing through.